go 6976 has been researched along with Insulin Resistance in 2 studies
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robinson, KA | 1 |
| Hegyi, K | 1 |
| Hannun, YA | 1 |
| Buse, MG | 1 |
| Sethi, JK | 1 |
| Kajita, K | 1 |
| Ishizuka, T | 1 |
| Miura, A | 1 |
| Ishizawa, M | 1 |
| Kanoh, Y | 1 |
| Yasuda, K | 1 |
2 other studies available for go 6976 and Insulin Resistance
| Article | Year |
|---|---|
Go-6976 reverses hyperglycemia-induced insulin resistance independently of cPKC inhibition in adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Carbazoles; Gene Expression Regulation; Humans; Hyperglycemia; In | 2014 |
The role of atypical and conventional PKC in dehydroepiandrosterone-induced glucose uptake and dexamethasone-induced insulin resistance.
Topics: Adipocytes; Adjuvants, Immunologic; Androstadienes; Animals; Antimetabolites; Carbazoles; Cells, Cul | 2000 |